From: Hypertriglyceridemic waist identifies HIV+ men and women at increased cardiometabolic risk
Low TG/Low WC | High TG/Low WC | Low TG/High WC | High TG/High WC | P value | |
---|---|---|---|---|---|
n (%) | 592 (25.50) | 856 (36.86) | 311 (13.39) | 563 (24.25) | - |
DEMOGRAPHICS | |||||
Women, n (%) | 284 (47.9) | 245 (28.62) | 145 (46.62) | 167 (29.66) | < 0.001 |
Age mean (± S) | 43.3 (6.7) | 44.4 (6.6) | 45.4 (7.7) | 46.9 (7.8) | < 0.001 |
Physical activity, n (%) | 232 (39.19) | 282 (32.94) | 103 (33.12) | 152 (27.00) | < 0.001 |
Smoke (> 10 cigs/day), n (%) | 187 (31.59) | 285 (33.29) | 73 (23.47) | 165 (29.31) | 0.010 |
Alcohol consumption, n (%) | 270 (45.61) | 363 (42.41) | 154 (49.52) | 279 (49.56) | 0.032 |
ANTHROPOMETRICS | |||||
BMI mean (± SD) | 21.2 (2.2) | 21.7 (2.3) | 26.3 (3.9) | 27.1 (3.8) | < 0.001 |
VAT cm3, median (IQR) | 75 (49; 103) | 100 (67; 138) | 136 (101; 194) | 172 (125; 236) | < 0.001 |
Waist Circumference cm, median (IQR) | 79 (75; 83) | 81 (77; 85) | 94 (90; 98) | 95 (91; 101) | < 0.001 |
Hip Circumference cm, median (IQR) | 87 (83; 90) | 86 (83; 89) | 94 (91; 97) | 94 (90.5; 98) | < 0.001 |
Thigh Circumference cm, median (IQR) | 45 (42.5; 48) | 45 (43; 48) | 49 (46; 52) | 49 (46; 52) | < 0.001 |
% of Leg Fat, median (IQR) | 12.6 (7.2; 19.9) | 7.7 (5.6; 12.7) | 18.1 (12.5; 26.2) | 14.0 (9.9; 21.1) | < 0.001 |
HIV history | |||||
IDU n (%) | 201 (33.95%) | 286 (33.41%) | 99 (31.83%) | 151 (26.82%) | < 0.001 |
CD4+ Nadir median (IQR) | 181 (78; 260) | 154 (59; 260) | 189 (90; 290) | 171.5 (63; 260) | 0.014 |
CD4+ Current median (IQR) | 499.5 (370; 672) | 523 (364; 700) | 492 (360; 658) | 543.5 (375; 737) | 0.113 |
VL undetectable n (%) | 363 (61.32) | 492 (57.48) | 190 (61.09) | 329 (58.44) | 0.432 |
Months of PI exposure median (IQR) | 24 (0; 60) | 35.5 (8; 69.5) | 30 (0; 58) | 39 (9;7269) | 0.005 |
Months of NNRTI exposure median (IQR) | 16 (0; 45) | 18 (0; 48) | 17 (0; 49) | 16 (0; 46) | 0.445 |
CARDIOVASCULAR | |||||
Framingham risk median (IQR) | 2 (1; 5) | 6 (2; 10) | 2 (1; 6) | 6 (2; 12) | < 0.001 |
Hypertension, n (%) | 131 (22.13) | 302 (35.28) | 119 (38.26) | 259 (46.00) | < 0.001 |
Albuminuria, n (%) | 38 (6.42) | 84 (9.81) | 24 (7.72) | 59 (10.48) | < 0.001 |
LIPID METABOLISM | |||||
Triglycerides median (IQR), mmol/L | 1.03 (0.81; 1.27) | 2.32 (1.87; 3.41) | 1.10 (0.89; 1.30) | 2.37 (1.85; 3.34) | < 0.001 |
Total cholesterol mean (± SD), mmol/L | 4.43 (1.09) | 5.05 (1.22) | 4.55 (1.10) | 5.17 (1.30) | < 0.001 |
HDL mean (± SD), mmol/L | 1.36 (0.44) | 1.05 (0.42) | 1.33 (0.41) | 1.06 (0.30) | < 0.001 |
LDL mean (± SD), mmol/L | 2.70 (0.84) | 3.02 (1.03) | 2.83 (0.91) | 3.09 (1.01) | < 0.001 |
ApoA1 mean (± SD), mg/dL | 148.7 (32.6) | 137.5 (26.8) | 149.9 (29.8) | 139.7 (27.0) | < 0.001 |
ApoB mean (± SD), mg/dL | 85.6 (23.4) | 108.8 (29.0) | 90.3 (24.3) | 110.3 (27.3) | < 0.001 |
HOMA-IR median (IQR) | 2.25 (1.39; 3.38) | 3.07 (2.04; 5.01) | 3.26 (2.21; 5.13) | 4.31 (2.74; 6.68) | < 0.001 |